Institutional shares held 76.6 Million
112K calls
240K puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 215.91%
# of Institutions 195


Latest Institutional Activity in SBTX

Top Purchases

Q1 2025
Bio Impact Capital LLC Shares Held: 1.31M ($0)
Q1 2025
Cormorant Asset Management, LP Shares Held: 1.6M ($0)
Q1 2025
Rubric Capital Management LP Shares Held: 1.03M ($0)
Q1 2025
Abrdn PLC Shares Held: 1M ($0)
Q1 2025
Nextech Invest, Ltd. Shares Held: 937K ($0)

Top Sells

Q1 2025
Alyeska Investment Group, L.P. Shares Held: 290K ($0)
Q1 2025
State Street Corp Shares Held: 2.03M ($0)
Q1 2025
Woodline Partners LP Shares Held: 600K ($0)
Q1 2025
Ubs Group Ag Shares Held: 591K ($0)
Q1 2025
Royce & Associates LP Shares Held: 643K ($0)

About SBTX

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.


Insider Transactions at SBTX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.39M Shares
From 9 Insiders
Exercise of conversion of derivative security 1.39M shares
Sell / Disposition
6.83M Shares
From 12 Insiders
Open market or private sale 6.83M shares

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX